These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomized trial. AinMelk Y Fertil Steril; 1996 Dec; 66(6):962-8. PubMed ID: 8941062 [TBL] [Abstract][Full Text] [Related]
3. Comparison of continuous versus sequential estrogen and progestin therapy in postmenopausal women. Clisham PR; de Ziegler D; Lozano K; Judd HL Obstet Gynecol; 1991 Feb; 77(2):241-6. PubMed ID: 1846438 [TBL] [Abstract][Full Text] [Related]
4. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group. Archer DF; Pickar JH; Bottiglioni F Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926 [TBL] [Abstract][Full Text] [Related]
5. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding. Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of conjugated estrogen plus medroxyprogesterone acetate versus tibolone in early postmenopausal Chinese women. Yang TS; Tsan SH; Chen CR; Chang SP; Yuan CC Zhonghua Yi Xue Za Zhi (Taipei); 1999 May; 62(5):308-15. PubMed ID: 10389286 [TBL] [Abstract][Full Text] [Related]
7. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016 [TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy in postmenopausal women. Yasui T; Uemura H; Takikawa M; Irahara M J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382 [TBL] [Abstract][Full Text] [Related]
10. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses. Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516 [TBL] [Abstract][Full Text] [Related]
11. Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement. Williams DB; Voigt BJ; Fu YS; Schoenfeld MJ; Judd HL Obstet Gynecol; 1994 Nov; 84(5):787-93. PubMed ID: 7936513 [TBL] [Abstract][Full Text] [Related]
12. Endometrial safety and bleeding pattern during a five-year treatment with long-cycle hormone therapy. Odmark IS; Bixo M; Englund D; Risberg B; Jonsson B; Olsson SE Menopause; 2005; 12(6):699-707. PubMed ID: 16278613 [TBL] [Abstract][Full Text] [Related]
13. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study. Langer RD; Landgren BM; Rymer J; Helmond FA; Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644 [TBL] [Abstract][Full Text] [Related]
14. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium]. Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831 [TBL] [Abstract][Full Text] [Related]
15. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of two hormone replacement therapy regimens on safety and efficacy variables. Siseles NO; Halperin H; Benencia HJ; Berg G; Pilnik S; Mesch V; Arrighi B; Wikinski RW Maturitas; 1995 Apr; 21(3):201-10. PubMed ID: 7616869 [TBL] [Abstract][Full Text] [Related]
17. Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group. Nand SL; Webster MA; Baber R; O'Connor V Obstet Gynecol; 1998 May; 91(5 Pt 1):678-84. PubMed ID: 9572210 [TBL] [Abstract][Full Text] [Related]
18. Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy. Luciano AA; Turksoy RN; Carleo J; Hendrix JW Obstet Gynecol; 1988 Jan; 71(1):39-43. PubMed ID: 2827082 [TBL] [Abstract][Full Text] [Related]
19. [Basic principles of hormone replacement therapy in the postmenopause]. Dören M Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374 [TBL] [Abstract][Full Text] [Related]
20. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate. Odmark IS; Jonsson B; Bäckström T Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]